Zobrazeno 1 - 10
of 88
pro vyhledávání: '"David P. Cistola"'
Publikováno v:
American Journal of Preventive Cardiology, Vol 15, Iss , Pp 100574- (2023)
Therapeutic Area: ASCVD/CVD Risk Factors Background: Previously we reported that the impact of fasting insulin on future CVD risk is modified by waist circumference (WC) and fasting glucose. Here, we tested the hypothesis that low-normal fasting gluc
Externí odkaz:
https://doaj.org/article/6ed604c6d5f2401c84c981415f396e81
Autor:
David P. Cistola, MD, PhD, Vipulkumar Patel, PhD, Sneha Deodhar, MS, Ina Mishra, PhD, Michelle D. Robinson, PhD, Alok K. Dwivedi, Ph.D.
Publikováno v:
American Journal of Preventive Cardiology, Vol 15, Iss , Pp 100576- (2023)
Therapeutic Area: Diabetes Background: Plasma water T2 is an early, global and practical biomarker of cardiometabolic health. It is measured by compact magnetic resonance relaxometry using separated human plasma. A prior goal was to determine whether
Externí odkaz:
https://doaj.org/article/5be4159376ad4a6888d55957772856ce
Publikováno v:
IEEE Access, Vol 9, Pp 73029-73045 (2021)
Diabetes is a major public health challenge affecting more than 451 million people. Physiological and experimental factors influence the accuracy of non-invasive glucose monitoring, and these need to be overcome before replacing the finger prick meth
Externí odkaz:
https://doaj.org/article/3a1670564ffa4119a5c78866f8796068
Publikováno v:
Biomarker Research, Vol 6, Iss 1, Pp 1-12 (2018)
Abstract Background Metabolic syndrome is a cluster of abnormalities that increases the risk for type 2 diabetes and atherosclerosis. Plasma and serum water T2 from benchtop nuclear magnetic resonance relaxometry are early, global and practical bioma
Externí odkaz:
https://doaj.org/article/2c49990ce5d4495da8c05ceb3dbc881f
Autor:
Michelle D. Robinson, Ina Mishra, Sneha Deodhar, Vipulkumar Patel, Katrina V. Gordon, Raul Vintimilla, Kim Brown, Leigh Johnson, Sid O’Bryant, David P. Cistola
Publikováno v:
Journal of Translational Medicine, Vol 15, Iss 1, Pp 1-19 (2017)
Abstract Background Metabolic syndrome (MetS) is a highly prevalent condition that identifies individuals at risk for type 2 diabetes mellitus and atherosclerotic cardiovascular disease. Prevention of these diseases relies on early detection and inte
Externí odkaz:
https://doaj.org/article/dd024087cf344d8d99f38aef8f44c1a7
Autor:
David P Cistola, Alok K Dwivedi
Publikováno v:
Circulation. 147
Introduction: The U.S. population includes a prevalent group of teens and young adults with early metabolic imbalance or EMI. This insidious condition includes markers of insulin resistance, particularly its interaction with adiposity, as well subcli
Autor:
David P. Cistola, Alok K. Dwivedi
Publikováno v:
Metabolism. 142:155469
Autor:
Valeria Diaz-Pacheco, Michelle D. Robinson, Stephen Atkinson, Diana F. Sandoval, David P. Cistola
Publikováno v:
Metabolism. 142:155491
Publikováno v:
Metabolism. 142:155464
Autor:
David P Cistola, Alok Dwivedi
Publikováno v:
Circulation. 145
Introduction: Overweight and obeseare widely reported risk factors for atherosclerotic cardiovascular disease(ASCVD). However, their true impact ondisease risk may be complicated by interactions between measures of adiposityand insulin resistance. Hy